Skip to content
DraconiticResearch
Search Sources API
181,716 studies31 sourcesUpdated 23 min ago
Peer-reviewedCC BY-NC-ND 4.0Obesity Pillars

Synthesized cardiometabolic, pulmonary, and sleep outcomes after bariatric surgery in adolescents with severe obesity: A systematic review and meta-analysis

4 affiliations
  1. 1Department of Pediatric Pulmonology, Allergy, Immunology and Sleep Medicine, Yale New Haven Children's Hospital, New Haven, CT, 06510, USA.
  2. 2St. Christopher's Hospital for Children, Philadelphia, PA, 19134, USA.
  3. 3Clinica Sierra Vista, Fresno, CA, USA.
  4. 4Department of Oral Medicine and Radiology, Chitwan Medical College, Bharatpur, Chitwan, 44207, Nepal.

Abstract

Background: To synthesize cardiometabolic, pulmonary, sleep-related, anthropometric, and safety outcomes after metabolic and bariatric surgery in adolescents with severe obesity.

Methods: This was a systematic review and meta-analysis conducted according to PRISMA 2020 and prospectively registered in PROSPERO (CRD420261354795). Five databases were searched for studies of adolescents aged approximately 10–19 years undergoing recognized metabolic or bariatric procedures. Two reviewers independently performed study selection, data extraction, and risk-of-bias assessment. Random-effects meta-analysis was used when studies were sufficiently comparable.

Results: Of 5110 records, 147 reports representing 101 unique studies or cohorts published from 1995 to 2026 were included. Follow-up ranged from 30 days to approximately 15 years. Across three independent randomized cohorts, surgery reduced body mass index by 9.39 kg/m2 at 2 years versus non-surgical care (95% CI −13.90 to −4.89; I2 = 88%; low certainty). Randomized evidence indicated lower triglycerides (mean difference −0.36 mmol/L, 95% CI −0.57 to −0.14; low certainty), whereas blood-pressure effects were indeterminate (very low certainty). Observational cohorts reported improvement or remission of type 2 diabetes, hypertension, dyslipidemia, and obstructive sleep apnea. Weight reduction was durable after gastric bypass and sleeve gastrectomy but smaller and less durable after gastric banding. Repeat objective sleep testing was reported in three studies and postoperative spirometry in one. No included report documented use of a validated asthma-control instrument, ambulatory blood-pressure monitoring, or vascular imaging as a pre- and postoperative outcome; diastolic function was reported once; diastolic function was reported once. Perioperative mortality and serious 30-day complications were uncommon, whereas reoperation and micronutrient deficiency remained important during extended follow-up.

Conclusions: Metabolic and bariatric surgery produces large body mass index reductions and multisystem improvement in adolescents with severe obesity; serious short-term complications and perioperative mortality were uncommon, but lifelong nutritional and multidisciplinary surveillance remains important. Most effect estimates remain uncertain, particularly for objective long-term sleep and pulmonary outcomes.

Related

  1. Beyond BMI: The Role of Visceral Adipose Tissue in Cardiometabolic Risk Stratification Among Children and Adolescents with Obesity—A Systematic Review
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Early-life risk factors and cardiometabolic outcomes in children and adolescents: a systematic review and meta-analysis
    Marco Brandimonte-Hernández, Francisco Javier Ruiz-Ojeda, Sophia M. Blaauwendraad +10
    BMC MedicinePeer-reviewedCC BY-NC-ND 4.0Obstetrics, gynaecology & paediatricsCrossref
  3. Excess adiposity and early cardiometabolic risk markers among adolescents and young adults in 70 countries: a multi-country cross-sectional study
    Setognal B. Aychiluhm, Vivian Isaac, Allen G. Ross +2
    eClinicalMedicinePeer-reviewedCC BY 4.0Epidemiology & public healthCrossref
  4. Pulmonary arterial hypertension-associated cerebellar impairment extends evidence linking cardiometabolic and neurodegenerative diseases.
    Michael W Schwartz, Karin E Bornfeldt
    The Journal of clinical investigationPeer-reviewedCC BYFull textNeurologyEurope PMCPMC
  5. Infliximab Monotherapy as First-Line Treatment for Hepatic, Splenic, and Pulmonary Sarcoidosis in a Patient With High Cardiometabolic Risk.
    Matilde Coimbra, Carolina Saca, Maria Carolina Carvalho +2
    CureusPeer-reviewedCC BYFull textPhysiologyEurope PMC
BibTeX
@article{lal2026synthesized,
  title = {{Synthesized cardiometabolic, pulmonary, and sleep outcomes after bariatric surgery in adolescents with severe obesity: A systematic review and meta-analysis}},
  author = {Purushottam Lal and Nitin Kumar and Surendra Gupta and Sabhyata Agrawal and Abhishek Gupta},
  journal = {Obesity Pillars},
  year = {2026},
  month = oct,
  doi = {10.1016/j.obpill.2026.100341},
  url = {https://doi.org/10.1016/j.obpill.2026.100341},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Synthesized cardiometabolic, pulmonary, and sleep outcomes after bariatric surgery in adolescents with severe obesity: A systematic review and meta-analysis
AU  - Purushottam Lal
AU  - Nitin Kumar
AU  - Surendra Gupta
AU  - Sabhyata Agrawal
AU  - Abhishek Gupta
PY  - 2026
DA  - 2026/10/09
JO  - Obesity Pillars
DO  - 10.1016/j.obpill.2026.100341
UR  - https://doi.org/10.1016/j.obpill.2026.100341
AB  - Background: To synthesize cardiometabolic, pulmonary, sleep-related, anthropometric, and safety outcomes after metabolic and bariatric surgery in adolescents with severe obesity.  Methods: This was a systematic review and meta-analysis conducted according to PRISMA 2020 and prospectively registered in PROSPERO (CRD420261354795). Five databases were searched for studies of adolescents aged approximately 10–19 years undergoing recognized metabolic or bariatric procedures. Two reviewers independently performed study selection, data extraction, and risk-of-bias assessment. Random-effects meta-analysis was used when studies were sufficiently comparable.  Results: Of 5110 records, 147 reports representing 101 unique studies or cohorts published from 1995 to 2026 were included. Follow-up ranged from 30 days to approximately 15 years. Across three independent randomized cohorts, surgery reduced body mass index by 9.39 kg/m2 at 2 years versus non-surgical care (95% CI −13.90 to −4.89; I2 = 88%; low certainty). Randomized evidence indicated lower triglycerides (mean difference −0.36 mmol/L, 95% CI −0.57 to −0.14; low certainty), whereas blood-pressure effects were indeterminate (very low certainty). Observational cohorts reported improvement or remission of type 2 diabetes, hypertension, dyslipidemia, and obstructive sleep apnea. Weight reduction was durable after gastric bypass and sleeve gastrectomy but smaller and less durable after gastric banding. Repeat objective sleep testing was reported in three studies and postoperative spirometry in one. No included report documented use of a validated asthma-control instrument, ambulatory blood-pressure monitoring, or vascular imaging as a pre- and postoperative outcome; diastolic function was reported once; diastolic function was reported once. Perioperative mortality and serious 30-day complications were uncommon, whereas reoperation and micronutrient deficiency remained important during extended follow-up.  Conclusions: Metabolic and bariatric surgery produces large body mass index reductions and multisystem improvement in adolescents with severe obesity; serious short-term complications and perioperative mortality were uncommon, but lifelong nutritional and multidisciplinary surveillance remains important. Most effect estimates remain uncertain, particularly for objective long-term sleep and pulmonary outcomes.
SN  - 2667-3681
ER  -